Filtered By:
Education: Study
Management: Economics

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 226 results found since Jan 2013.

Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide
CONCLUSIONS: The requirement for calibration to replicate the outcomes observed in SUSTAIN 6 suggests that the reductions in risk of cardiovascular complications observed with once-weekly semaglutide cannot be solely explained by differences in conventional risk factors. Accurate estimation of the risk of diabetes-related complications using methods such as calibration is important to ensure accurate cost-effectiveness analyses are conducted.PMID:37525970 | DOI:10.1080/13696998.2023.2240957
Source: Journal of Medical Economics - August 1, 2023 Category: Health Management Authors: Sasha Berry Barrie Chubb Annabel Acs Edel Falla Akanksha Verma Samuel Jp Malkin Barnaby Hunt Andrew J Palmer Source Type: research

Health-related quality of life of community-dwelling stroke survivors: a comparison of fallers and non-fallers - Hong E.
[Purpose] The purpose of this study was to compare the health-related quality of life (HRQOL) of stroke survivors between fallers and non-fallers. [Subjects] The subjects were community-dwelling stroke patients (n = 4,560) in South Korea. All stroke patien...
Source: SafetyLit: All (Unduplicated) - December 11, 2015 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran.
CONCLUSIONS: The balance of hospitalization and rehabilitation costs and QALYs support the conclusion that treatment with intravenous tPA in the 4.5 hour time window is cost-effective from the perspectives of third party payer and inclusion of tPA in the insurance benefit package is reasonable. PMID: 29105528 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - November 8, 2017 Category: Health Management Tags: J Med Econ Source Type: research

Economic evaluation of human urinary kallindinogenase for patients with acute ischemic stroke in China.
CONCLUSION: This economic evaluation study indicates that administrating HUK is a cost-saving therapy compared with NBP for managing blood flow during AIS in Chinese setting. PMID: 29706099 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - May 2, 2018 Category: Health Management Tags: J Med Econ Source Type: research

Economic burden of stroke: a systematic review on post-stroke care
ConclusionThe highest PSC costs were observed in the USA, with rehabilitation services being the main cost driver. Due to diversity in reporting, it was not possible to conduct a detailed cost analysis addressing different segments of services. Further approaches should benefit from the advantages of administrative and claims data, focusing on inpatient/outpatient PSC cost and its predictors, assuring appropriate resource allocation.
Source: The European Journal of Health Economics - June 16, 2018 Category: Health Management Source Type: research

The weekend effect revisited: evidence from the Upper Austrian stroke registry
AbstractEmpirical evidence on the so-called ‘weekend-effect’ on stroke mortality is mixed with some studies reporting significantly higher mortality for weekend admissions and others finding no difference. The aim of this paper is to enhance the evidence on the weekend-effect on stroke mortality using a rich stroke registry data set from Upper Austria and to discuss underlying reasons for the heterogeneity in results. Using logistic regressions and ordinary least squares regressions with hospital and year-fixed effects, the outcomes of weekend versus weekday admissions are compared for patients admitted to 16 hospitals...
Source: The European Journal of Health Economics - February 12, 2019 Category: Health Management Source Type: research

Stroke incidence in survivors of carbon monoxide poisoning in South Korea: a population-based longitudinal study - Kim HH, Choi S, Jung YS, Min YG, Yoon D, Lee SE.
BACKGROUND Carbon monoxide (CO) poisoning is a suspected risk factor for stroke. However, the association between stroke occurrence and carbon monoxide poisoning remains unclear. This nationwide study in Korea analyzed the incidence of stroke in survivors ...
Source: SafetyLit - November 2, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

The importance of previous lifetime trauma in stroke-induced PTSD symptoms and mental health outcomes - Kronenberg G, Sch öner J, Levitanus M, Alvarado Balderrama AV, Geran R, Laumeier I, Schlattmann P, Nelson CP, Endres M, Gertz K.
The 'Stroke Complications after Traumatic Experiences and Stress' (SATURN) study was designed to investigate the effects of a prior traumatic event on PTSD symptoms triggered by a subsequent stroke. First-ever ischemic stroke patients were surveyed 9-13 mo...
Source: SafetyLit - November 7, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China
ConclusionsEarlier treatment of acute ischemic stroke patients with EVT in China increases lifetime QALYs and the economic value of care without any net increase in lifetime costs. Thus, healthcare policies should aim to improve efficiency of pre-hospital and in-hospital workflow processes to reduce the onset-to-puncture duration in China.
Source: Health Economics Review - January 6, 2022 Category: International Medicine & Public Health Source Type: research

Health economic evaluation of the 'Flying Intervention Team as a novel stroke care concept for rural areas: study protocol of the TEMPiS-GÖA study
The objective of the present paper is to describe the methods for the economic evaluation (TEMPiS-Gesundheitsökonomische Analyse (TEMPiS-GÖA)) alongside the TEMPiS-FIT study to determine whether the new form of care is cost-effective compared with standard care. Methods and analysis The within-trial cost-effectiveness analysis (CEA) and cost–utility analysis (CUA) will be performed from a statutory health insurance perspective as well as from a societal perspective over the time horizon of 12 months after the patients’ hospital discharge. Direct costs from outpatient and inpatient care are coll...
Source: BMJ Open - September 20, 2022 Category: General Medicine Authors: Coors, M., Flemming, R., Schüttig, W., Hubert, G. J., Hubert, N. D., Sundmacher, L. Tags: Open access, Health economics Source Type: research

Comparison of serum lipoprotein (a) level between non-cardioembolic ischemic stroke and traumatic brain injury - Gheini MR, Jafari E, Ahmadi A, Togha M, Saidinia S, Moradi M.
BACKGROUND: Numerous studies have reported higher lipoprotein (a) levels among stroke patients than controls, but it could be due to an acute phase reaction. The aim of this study was to compare lipoprotein (a) levels between patients with ischemic stroke ...
Source: SafetyLit: All (Unduplicated) - May 23, 2014 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Locate New Stroke Centers by Need, Not Economics Locate New Stroke Centers by Need, Not Economics
Careful consideration of where new comprehensive stroke centers are located will maximize patients who will benefit, a new study shows, but the US system is not currently set up to ensure that. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Clinical Practice Variation Needs to be Considered in Cost-Effectiveness Analyses: A Case Study of Patients with a Recent Transient Ischemic Attack or Minor Ischemic Stroke
Conclusions If important practice variation exists, hospital-level CEAs should be performed. These CEAs should include an assessment of the feasibility and costs of switching to a different strategy.
Source: Applied Health Economics and Health Policy - April 28, 2015 Category: Health Management Source Type: research